| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 06/25/2009 | WO2009079337A1 Additive composition for ep greases with excellent antiwear and corrosion properties |
| 06/25/2009 | WO2009077796A2 Process for the preparation of amine functional phosphoric amides |
| 06/25/2009 | WO2009077741A2 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents |
| 06/25/2009 | WO2009077497A2 Azolyl methyl oxiranes, the use thereof, and agents containing them |
| 06/25/2009 | WO2009077471A2 Azolylmethyloxiranes, use thereof and agents containing the same |
| 06/25/2009 | WO2009077443A2 Azolylmethyloxiranes, use thereof and agents containing the same |
| 06/25/2009 | US20090163740 Ligands for metals as catalysts for carbon-carbon bond formation |
| 06/25/2009 | US20090163732 Low Decomposition Storage of a Tantalum Precursor |
| 06/25/2009 | US20090163725 Phosphonic acid diester derivative and method for producing thereof |
| 06/25/2009 | US20090163724 Carbonylation of Ethylenically Unsaturated Compounds |
| 06/25/2009 | US20090163723 Method for producing sulfonium fluorinated alkylfluorophosphate |
| 06/25/2009 | US20090163712 Processes for preparing hiv reverse transcriptase inhibitors |
| 06/25/2009 | US20090163627 Symmetric Cyclic Phosphonate Compound, Method of Preparing the Same and Flame Retardant Styrenic Resin Composition Including the Same |
| 06/25/2009 | US20090163446 Diazonamide analogs with improved solubility |
| 06/25/2009 | US20090163444 Phospho-indoles as hiv inhibitors |
| 06/25/2009 | US20090163443 from the culture of Streptomyces vayuensis strain; Nonadeca-6-enoic acid-3-(hexadecyloxy-hydroxy-thiophosphoryloxy)-quinoxalin-2-yl ester, useful particularly for prevention of obesity and treatment of diabetes, sleep apnea, nervous system, cardiovascular and gastrointestinal disorders |
| 06/25/2009 | US20090162420 Matrix-Controlled Transdermal System Comprising Salts of ACE Inhibitor Dicarboxylic Acids |
| 06/25/2009 | DE102008064234A1 Symmetrische cyclische Phosphonatverbindung, Verfahren zu deren Herstellung und diese einschließende flammhemmende Styrolharzzusammensetzung Symmetric cyclic phosphonate compound, to processes for their preparation and enclosing flame-retardant styrene resin composition |
| 06/25/2009 | DE102007061436A1 Verfahren zur Gewinnung von Fettbegleitstoffen aus Kraftstoffen und Verwendung dieses Verfahrens A process for the production of fat-accompanying substances from gasoline and the use of this method |
| 06/25/2009 | DE102007060651B3 Asphalten-Dispergatoren auf Basis von Phosphonsäuren Asphaltene dispersants based on phosphonic |
| 06/25/2009 | CA2709749A1 3-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]-tetrazine-8-carboxylic acid amides and their use |
| 06/25/2009 | CA2708148A1 Reagents and methods for the beta-keto amide synthesis of a synthetic precursor to immunological adjuvant e6020 |
| 06/25/2009 | CA2707615A1 Azolylmethyloxiranes, their use and compositions comprising them |
| 06/24/2009 | CN101463046A Caged bicyclic phosphate flame retardant, and preparation and use thereof |
| 06/24/2009 | CN101463045A Thiophosphate nucleotide compound |
| 06/24/2009 | CN101463044A Mechanochemical synthesis of ammonium glyphosate preparation |
| 06/24/2009 | CN101463043A Production method of edible concentrate soya bean lecithin |
| 06/24/2009 | CN100503624C Process for preparing phosphine oxamate and its derivatives |
| 06/24/2009 | CN100503623C Process for preparing high-purity butoxy ethyl phosphate |
| 06/24/2009 | CN100503622C Organophosphorus ester preparation method |
| 06/24/2009 | CN100503621C Method for synthesizing diphosphate using ester exchange method |
| 06/24/2009 | CN100503600C Pesticidal heterocycles |
| 06/24/2009 | CN100503589C Sulphona mide derivatives as prodrugs of aspartyl protease inhibitors |
| 06/24/2009 | CN100503580C Irreversible inhibitor of tyrosine kinase |
| 06/23/2009 | US7550501 Compounds and methods for treating toll-like receptor 2-related diseases and conditions |
| 06/23/2009 | US7550497 sulfonamidophosphonate-functional heteroaryl compounds that contain SO2-NH-P(O)(-OR)2 group; antiinflammatory and analgesics; e.g. N-[4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]phenylsulfonyl]phosphoramidic acid; injectable COX-2 inhibitors |
| 06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
| 06/23/2009 | US7550449 4-(alkylcarbonyloxymethyl)-2-oxo-2-methoxy-1,2-oxaphospholane; anticancer, antimetastasis agents |
| 06/23/2009 | US7550448 Therapeutic compounds |
| 06/23/2009 | US7550407 System suitable for the hydrocyanation of olefinically unsaturated compounds |
| 06/23/2009 | US7550406 hydrogenation catalyst comprising a bidentate ligand, a monodentate ligand, and a transition metal catalyst; for catalytic converting olefin ethylene or 1-butene with a gas mixture of hydrogen and carbon monoxide to produce an aldehyde; synergistic, increase catalytic activity and stability |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2405046C Stabilized pharmaceutical compositions comprising a calcium blocker and an alkaline material |
| 06/18/2009 | WO2009076622A2 Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof |
| 06/18/2009 | WO2009076473A1 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl n,n-bis(2- chloroethyl)phosphorodiamidates |
| 06/18/2009 | WO2009075870A1 Compounds and methods for the treatment of cancer |
| 06/18/2009 | WO2009074733A2 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same |
| 06/18/2009 | WO2009074351A2 Solid forms of tenofovir disoproxil |
| 06/18/2009 | WO2009009153A9 Purification of rosuvastatin intermediate by thin film evaporation and chemical method |
| 06/18/2009 | US20090156851 Ferrocene-Diphosphine Ligands |
| 06/18/2009 | US20090156849 Catalyst for Asymmetric Synthesis, Ligand for Use Therein, and Process for Producing Optically Active Compound through Asymmetric Synthesis Reaction Using Them |
| 06/18/2009 | US20090156769 hysteresis; for use as tire treads; wear resistance; skid resistance; rolling resistance |
| 06/18/2009 | US20090156559 2-{[2-(Diethylamino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidate; chemical intermediates; free of by-products acrolein; release "cyclophosphate mustards" and do not require metabolic activation; anticarcinogenic agents; antitumor agents; autoimmune diseases |
| 06/18/2009 | US20090156558 Phosphonate analogs of antimetabolites |
| 06/18/2009 | US20090156557 Kinase inhibitors |
| 06/18/2009 | US20090156556 Aminopropanol derivatives |
| 06/18/2009 | US20090156555 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 06/18/2009 | US20090156545 Substituted Phosphate Esters of Nucleoside Phosphonates |
| 06/18/2009 | DE102008061429A1 Sterisch gehinderte phenolische Phosphonate und flammenfeste Polycarbonatharzzusammensetzung unter Verwendung derselben Hindered phenolic phosphonates and flame resistant polycarbonate resin composition using the same |
| 06/18/2009 | CA2709219A1 Solid forms of tenofovir disoproxil |
| 06/18/2009 | CA2708369A1 Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof |
| 06/18/2009 | CA2705467A1 Compounds and methods for the treatment of cancer |
| 06/17/2009 | EP2070935A1 Novel compound, composition comprising the same, and process for production of polymerizable amide |
| 06/17/2009 | EP2070930A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 06/17/2009 | EP2069460A2 Fluorescent cell markers |
| 06/17/2009 | EP2069371A1 Organo-arsenoxide compounds and use thereof |
| 06/17/2009 | EP2069370A2 Microorganism killing compounds |
| 06/17/2009 | EP1664046B1 Aza-quinolinol phosphonate integrase inhibitor compounds |
| 06/17/2009 | EP1472230B1 Ansamycins having improved pharmacological and biological properties |
| 06/17/2009 | CN101460512A Phosphine transition metal complex, method for producing the same and antitumor agent |
| 06/17/2009 | CN101460511A Process for production of aminated phosphoric acid ester compound, flame-retardant resin, and flame-retardant resin composition |
| 06/17/2009 | CN101456880A Phosphamidon amphipathic phthalocyanine derivates, preparation method and application thereof in phototherapy medicament preparation |
| 06/17/2009 | CN101456879A Method for preparing combustion inhibitor bisphenol A bis(diphenyl phosphate) |
| 06/17/2009 | CN100500679C Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage |
| 06/17/2009 | CN100500678C Process of glycine method for preparing glyphosate |
| 06/17/2009 | CN100500677C Caffeoyl guinic acid-1-phosphate and its preparation and use |
| 06/17/2009 | CN100500676C Process for preparing high purity soy phoshatidylcholine without lysophosphatide |
| 06/16/2009 | US7547807 Method for producing phosphonium salts |
| 06/16/2009 | US7547796 Organometallic compounds, processes for the preparation thereof and methods of use thereof |
| 06/16/2009 | US7547784 For analyzing phosphorylated substances; polyamine ligand such as N,N,N',N'-tetrakis((6-methyl-2-pyridyl)methyl)-1,3-diamino-2-hydroxypropane reacted with zinc acetate |
| 06/16/2009 | US7547720 di-tert-butyl 4-{[1-(3,3-dimethyl-2-oxobutyl)-6-methoxy-1-H-indazole-3-yl]carbonyl}benzylphosphate; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, elevated intraoccular pressure in the eye |
| 06/16/2009 | US7547709 Prevent free radical cellular damage; oxidation resistant additive for fuels, lubricants, rubbers, polymers, solvents, chemical and foodstuff; lipid and water soluble vitamin c, vitamin e |
| 06/16/2009 | US7547686 Combretastatin A-3 prodrug |
| 06/16/2009 | US7547685 Therapeutic substituted pyrrolidone compounds |
| 06/16/2009 | CA2574904C Antiretroviral enantiomeric nucleotide analogs |
| 06/16/2009 | CA2343732C Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto |
| 06/11/2009 | WO2009072769A2 Process for preparing risedronate sodium as anhydrous and hydrate forms |
| 06/11/2009 | WO2009072591A1 Method for producing high-purity phosphite chloride |
| 06/11/2009 | WO2009050394A3 Use of cyclovinyl phosphine/copper complexes as arylation catalysts |
| 06/11/2009 | WO2006119504A3 Fused heterocyclic compounds, and compositions and uses thereof |
| 06/11/2009 | US20090149648 Nucleotide analogs |
| 06/11/2009 | US20090149587 Sterically Hindered Phenolic Phosphonates and Polycarbonate Resin Composition Using the Same |
| 06/11/2009 | US20090149427 Pharmaceutically acceptable salts and hydrates of risedronic acid |
| 06/11/2009 | US20090149400 Anti-proliferative compounds, compositions, and methods of use thereof |
| 06/11/2009 | US20090145757 Redox Polymers |
| 06/10/2009 | EP2067808A1 New polymer and polymer light-emitting device using the same |
| 06/10/2009 | EP2067807A1 New polymer and polymer light-emitting device using the same |
| 06/10/2009 | EP2067782A1 Heteroacene derivative, tetrahaloterphenyl derivative, and their production methods |
| 06/10/2009 | EP2066680A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 06/10/2009 | EP2066633A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |